about
K153R polymorphism in myostatin gene increases the rate of promyostatin activation by furinRole of pro-IGF-II processing by proprotein convertase 4 in human placental developmentHuman alpha-defensins neutralize anthrax lethal toxin and protect against its fatal consequencesFurin at the cutting edge: from protein traffic to embryogenesis and diseaseCleavage targets and the D-arginine-based inhibitors of the West Nile virus NS3 processing proteinaseUnexpected similarity between the cytosolic West Nile virus NS3 and the secretory furin-like serine proteinasesA unified model for bone-renal mineral and energy metabolismSubtilisin-like proprotein convertase expression, localization, and activity in the human retina and optic nerve headFangchinoline inhibits human immunodeficiency virus type 1 replication by interfering with gp160 proteolytic processingIdentification of a small molecule that selectively inhibits mouse PC2 over mouse PC1/3: a computational and experimental studySoluble form of the (pro)renin receptor is augmented in the collecting duct and urine of chronic angiotensin II-dependent hypertensive ratsInhibitory potency and specificity of subtilase-like pro-protein convertase (SPC) prodomains.Cationic polyamines inhibit anthrax lethal factor proteaseIdentification of inhibitors using a cell-based assay for monitoring Golgi-resident protease activity.Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.Entecavir combined with furin inhibitor simultaneously reduces hepatitis B virus replication and e antigen secretion.Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins.Simultaneous rather than ordered cleavage of two sites within the BMP4 prodomain leads to loss of ligand in micePax6 directly down-regulates Pcsk1n expression thereby regulating PC1/3 dependent proinsulin processing.Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma.Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy.Identification of proSAAS homologs in lower vertebrates: conservation of hydrophobic helices and convertase-inhibiting sequences.Differential neuroprotective potential of CRMP2 peptide aptamers conjugated to cationic, hydrophobic, and amphipathic cell penetrating peptidesFurin is the major processing enzyme of the cardiac-specific growth factor bone morphogenetic protein 10.Identification of protein tyrosine phosphatase receptor gamma extracellular domain (sPTPRG) as a natural soluble protein in plasma.Group X secreted phospholipase A2 proenzyme is matured by a furin-like proprotein convertase and releases arachidonic acid inside of human HEK293 cells.Synthetic small molecule furin inhibitors derived from 2,5-dideoxystreptamineCationic Cell-Penetrating Peptides Are Potent Furin Inhibitors.Identification of potent and compartment-selective small molecule furin inhibitors using cell-based assays.Inhibition of prohormone convertases PC1/3 and PC2 by 2,5-dideoxystreptamine derivatives.Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases.The evolving field of biodefence: therapeutic developments and diagnostics.Protection against anthrax toxemia by hexa-D-arginine in vitro and in vivo.Proprotein convertase inhibition: Paralyzing the cell's master switches.Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.A small-molecule furin inhibitor inhibits cancer cell motility and invasiveness.Generation and characterization of non-competitive furin-inhibiting nanobodies.Proteases for processing proneuropeptides into peptide neurotransmitters and hormones.Furin Cleavage of L2 during Papillomavirus Infection: Minimal Dependence on CyclophilinsPurification of the proprotein convertase furin by affinity chromatography based on PC-specific inhibitors.
P2860
Q24311653-0451DE97-8BB3-4EF2-B4B3-EA07B45C07ABQ24534366-CB0A9640-262F-4C6D-BD9A-42E0DAF46434Q24555744-593DA3A0-F4B9-43FD-87FF-5296F5170DA9Q24670432-1B7A748F-4EFB-4CF5-92F1-FA1D9BD8DFA0Q27472859-477D51CD-99C2-4DE4-A29F-FF0209380609Q27472861-F6A8F136-3DD9-4987-960E-4F76B96A03A4Q27690863-11337940-5347-483F-8F75-AD6C945832D9Q28240099-9CB0AC7F-0C12-478C-BF03-14FAB3BEA6E5Q28480389-3DCA75E3-8DAC-4317-9E54-EE8AF9FB17D3Q28486655-A9BC573E-7B84-433B-984B-FF5B2099380AQ28566409-EC85246D-9A33-4571-8F6B-E255ED3FF675Q30769503-8E3B553D-1C79-4766-934B-106EC88EA304Q33246181-612B45B5-C3BA-453A-97C0-C5533BECC28BQ33275047-9411F690-82A7-4371-B636-B802E6A73ED5Q33783323-312D0639-8A98-476B-A84C-66B3721AA740Q34256771-0C28B0DB-C656-4771-8B3F-95B86B7B8370Q34332728-459480CE-174E-4539-A191-AF3283184E80Q34341692-090695B9-FD04-4A1F-A5B7-F71B93B583C0Q34442538-6F6D6389-45F9-46EC-BFC9-4494747A0099Q34657401-C15601F1-6C52-459F-9C4E-59DC01AE93FBQ34679398-74AB1206-9974-4CCE-8170-8C60FED0908FQ34864471-F87AD8B9-DAFB-498E-997B-9387CA438F1AQ35012677-89D32D46-F58E-420F-BFD2-5E259BCC9924Q35067671-3A8D249E-ED35-4AD6-8064-12DA4CE60FD6Q35182285-225C4844-9A94-4CCA-B51C-3E694452E690Q35378256-CD975540-A3C1-4AD1-87C0-FEA5377A1978Q35544367-769B434F-427B-4ED0-BC78-03A048C0792FQ35673837-4035E51C-DCBF-46C6-8A34-B4E15A2DA7D6Q35744263-981DAF6B-1234-4BBA-85F1-E91F748D43D4Q35776764-1873CA90-B388-48B0-9160-8C511507C300Q36052463-4B25A659-C356-4B9A-93B5-353E9C82E4A7Q36085668-F30DC974-3D9D-430F-87C3-18FD6EAE541BQ36228556-86877F7E-D9DF-49CB-8717-A95B6EDEB10EQ36358957-1791D736-89B6-48CB-91A1-704F5F14FF37Q36468902-A8DFD0F4-EFE2-447B-9FE3-5BFCD159754AQ36528189-CF61FB93-960F-403D-B188-80B9031D8D7CQ36533737-7778272F-B00A-4337-B33D-90F86C66F678Q37053834-874F121A-4753-447A-8BDB-2691A95C52DEQ37073350-193CE856-A230-4CE2-BC79-CBAF535531D4Q37217236-F8E57EF2-76E9-4F31-8C57-AC396CC6B733
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Polyarginines are potent furin inhibitors.
@ast
Polyarginines are potent furin inhibitors.
@en
type
label
Polyarginines are potent furin inhibitors.
@ast
Polyarginines are potent furin inhibitors.
@en
prefLabel
Polyarginines are potent furin inhibitors.
@ast
Polyarginines are potent furin inhibitors.
@en
P2093
P356
P1476
Polyarginines are potent furin inhibitors.
@en
P2093
P304
36741-36749
P356
10.1074/JBC.M003848200
P407
P577
2000-11-01T00:00:00Z